Deutsche Bank AG Buys 28,677 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Deutsche Bank AG raised its holdings in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 48.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 87,811 shares of the company's stock after acquiring an additional 28,677 shares during the quarter. Deutsche Bank AG owned about 0.07% of AdaptHealth worth $836,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Bridgeway Capital Management LLC lifted its stake in shares of AdaptHealth by 27.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 1,324,043 shares of the company's stock worth $12,605,000 after buying an additional 283,143 shares during the last quarter. BNP Paribas Financial Markets bought a new stake in AdaptHealth during the 4th quarter valued at approximately $229,000. Ameriprise Financial Inc. boosted its stake in AdaptHealth by 11.7% during the 4th quarter. Ameriprise Financial Inc. now owns 627,998 shares of the company's stock valued at $5,979,000 after purchasing an additional 65,606 shares during the period. Northern Trust Corp grew its holdings in AdaptHealth by 11.1% in the 4th quarter. Northern Trust Corp now owns 1,172,265 shares of the company's stock valued at $11,160,000 after buying an additional 116,981 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in AdaptHealth by 16.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 73,990 shares of the company's stock worth $705,000 after buying an additional 10,451 shares during the period. 82.67% of the stock is owned by institutional investors.

AdaptHealth Price Performance

NASDAQ AHCO traded up $0.08 during trading on Friday, reaching $9.06. 1,273,745 shares of the company traded hands, compared to its average volume of 1,286,034. AdaptHealth Corp. has a 1-year low of $7.11 and a 1-year high of $11.90. The company has a market cap of $1.22 billion, a price-to-earnings ratio of -5.49, a P/E/G ratio of 1.08 and a beta of 1.64. The stock's 50 day moving average price is $8.99 and its two-hundred day moving average price is $9.61. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Royal Bank of Canada dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday, May 8th. Truist Financial cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Robert W. Baird increased their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. UBS Group lowered their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, February 13th. Finally, Canaccord Genuity Group raised their price objective on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, AdaptHealth presently has a consensus rating of "Buy" and a consensus target price of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.